Delivery Order SPE2DB20D7066-SPE2DB25FC4HH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,816.89 on August 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, making...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count) under a firm fixed price contract valued at $3,300.54. This non-set-aside award is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply support...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.74 on August 14, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,089.08. The contract is firm fixed price with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025, with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count). This firm fixed-price contract, valued at $2,602.40, represents a non-competitive award and is scheduled for completion by July 31, 2025. The pharmaceutical product will be performed and delivered from the contractor's Conshohocken facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (quantity 60) under a firm fixed-price contract valued at $4,135.61, with an ultimate completion date of August 4, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4HHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) valued at $6,118.16 with a firm fixed price structure. This competitively awarded, non-set-aside contract was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio with the DLA demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This award supports the Defense Health Agency and other government healthcare systems through the DLA's Medical Supply Chain network, fulfilling critical pharmaceutical distribution needs for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/12/25 |